- Filing requirements governing market operations are in effect, involving Nasdaq and the SEC.
- United Therapeutics filed required documents for executive stock transactions and listed its stock on the exchange.
United Therapeutics disclosed stock sales by CEO Martine Rothblatt via required SEC filing.
6 reports, 3 independent
Updated Sun 00:00
Mostly repetition
- Reports
- 6
- Developments
- 1
- Repetition
- 83%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
United Therapeutics disclosed stock sales by CEO Martine Rothblatt via required SEC filing.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
United Therapeutics
biotech company based in Silver Spring, Maryland, United States
Nothing else this week.
-
SEC
Slovak company
Related events
- Adam Roth disclosed a stock acquisition in an SEC filing on October 18, 2026.
- Insider purchase disclosed via SEC filing for Transcontinental Realty Investors, Inc. on August 6, 2026.
- Goldman Sachs CEO David M. Solomon sold shares and filed the transaction with the SEC.
- Beta Technologies disclosed insider share sales via Form 4 filing with the SEC.
- Sera Prognostics Inc. disclosed an insider stock transaction via a legal filing with the SEC on October 13, 2026.